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Abstract: Substantial evidence supports the effect of the Mediterranean Diet (MD) for managing
chronic diseases, although trials have been primarily conducted in Mediterranean populations.
The efficacy and feasibility of the Mediterranean dietary pattern for the management of chronic
diseases has not been extensively evaluated in non-Mediterranean settings. This paper aims to
describe the development of a MD model that complies with principles of the traditional MD
applied in a multiethnic context. Optimal macronutrient and food-based composition was defined,
and a two-week menu was devised incorporating traditional ingredients with evidence based on
improvements in chronic disease management. Strategies were developed for the implementation of
the diet model in a multiethnic population. Consistent with the principles of a traditional MD, the MD
model was plant-based and high in dietary fat, predominantly monounsaturated fatty acids from
extra virgin olive oil. Fruits, vegetables and wholegrains were a mainstay, and moderate amounts of
nuts and seeds, fish, dairy and red wine were recommended. The diet encompassed key features
of the MD including cuisine, biodiversity and sustainability. The MD model preserved traditional
dietary components likely to elicit health benefits for individuals with chronic diseases, even with the
adaptation to an Australian multiethnic population.
Keywords: Mediterranean diet; dietary intervention; diet; nutrition; translation; non-alcoholic fatty
liver disease; cardiovascular disease
1. Introduction
There is a substantial body of evidence to support the efficacy of the Mediterranean Diet (MD)
in chronic disease prevention and management [1]. In this regard, results from several intervention
studies support the efficacy of a MD for individuals with cardiovascular disease (CVD) as well as
a broad range of associated disease states, including metabolic syndrome, type 2 diabetes mellitus
(T2DM), cognitive function decline, depression and anxiety, autoimmune diseases, cancer and
non-alcoholic fatty liver disease (NAFLD) [2–4]. As inflammation drives insulin resistance and
oxidative stress [5,6], the anti-inflammatory and antioxidant properties of the MD pattern are proposed
to slow the progression of some of the oxidative damage associated with the aforementioned clinical
conditions [7,8].
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Some of the proposed benefits of the MD pertain to the dietary pattern as a whole.
This encompasses overall macro and micronutrient composition, the variety of foods included as well
as the combination, preparation and consumption of these foods which contribute to the synergistic
effect of the food matrix [9]. The combination of foods and how these are traditionally prepared is
often referred to as cuisine, and this is a key element of the MD that is likely to contribute to added
health benefits [10].
The majority of clinical trials which have assessed the efficacy of the MD have been conducted
in Mediterranean populations, where this dietary pattern and these types of foods are familiar [1].
Embedding the principles of a MD in non-Mediterranean populations worldwide with different
habitual food cultures remains a great challenge. Australia is a culturally diverse nation, with almost
half the population (49%) having either been born overseas or with at least one parent born
overseas [11]. Given the high prevalence of chronic disease in Australia, and the scientific evidence
base of the MD, assessing the efficacy of the diet for the prevention and management of these diseases
in this population group is warranted. However, given the heterogeneity around the definitions and
interpretations of what constitutes a MD intervention, researchers need to be transparent about the
exact methods and dietary prescriptions used to ensure reproducibility and translation of favourable
effects for other research studies and to drive practice change [12].
The current paper provides the rationale and process undertaken for the development of a MD
model intervention in two clinical trials, currently underway. Protocols for each study are presented
elsewhere Papamiltiadous et al. [13] and Itsiopoulos et al. [14]. In this context, the specific aims of
the present study were (1) to identify the nutrient composition profiles of previous MD interventions
delivered to Mediterranean and Australian populations; (2) to identify the key dietary and food-based
components within the MD (with evidence-based health benefits) and to use these to develop key
food intake recommendations; (3) to develop a two-week meal plan based on the nutrient composition
profile and the key food intake recommendations identified in the previous steps; and (4) to assess the
barriers to translatability of this dietary pattern to multiethnic Australian populations with chronic
disease and to develop strategies to overcome these.
2. Methodological Steps to Address Each Specific Aim
A MD intervention for provision in an Australian, multiethnic population with diagnosed NAFLD
and CVD, undergoing clinical trial conditions, was developed using the below steps which are
summarized in Figure 1.
2.1. Step One: Identification of the Nutrient Composition Profile of Previous MD Interventions Delivered to
Mediterranean and Australian Populations
In determining the key nutrients required to achieve a MD, it was important to establish a clear
definition of a ‘MD pattern’ using a strong evidence base. This included using MD interventions
that have successfully translated this dietary pattern and achieved health benefits. There have been
a number of trials published, which refer to and apply a MD intervention; however, the nutrient
composition across the literature remains inconsistent [12]. Therefore, the authors used the Cretan MD
as the definition for this MD model, which was determined using published data from trials based on
the archetypal traditional Cretan (Greek) MD [15]. These dietary practices have been the most pivotal
in demonstrating prevention and management of chronic disease [16–18].
A comprehensive assessment of MD studies, including seminal MD trials in Mediterranean
regions and smaller clinical trials implemented in the Australian context, was conducted. Nutrient
composition data is depicted in Table 1. From this assessment the nutrient compositions for this
intervention were derived and are discussed below.
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Figure 1. A schematic summarising the key methodological steps taken to develop a Mediterranean
Diet model for an Australian multicultural setting. MD: Mediterranean Diet.
Nutrients 2018, 10, 465 4 of 20
Table 1. Nutrient data from the seminal Keys study and subsequent clinical trials within Mediterranean regions and clinical trials using a Mediterranean diet in
Australian populations.
Trials
7 Countries Study Diabetes Cross Over PREDIMED The Medi-RIVAGE NAFLD Cross Over
Keys et al. [15] (Cohort) Itsiopoulos et al. [19](Intervention)
Estruch et al. [20]
(Intervention)
Vincent et al. [21]
(Intervention)
Ryan et al. [4]
(Intervention)
Dietary data Prospective cohort
Feeding trial, full
provision of diet. Data is
recommended diet ˆ
Data is from diet
consumed *
Data is from
recommended diet ˆ
Feeding trial, full
provision of diet. Data is
the recommended diet ˆ
Population Mediterranean Non-Mediterranean(Australia) Mediterranean (Spain) Mediterranean (Spain)
Non-Mediterranean
(Australia)
Nutrients
Energy (MJ) - 11.9 9.2 - 11.3
Protein (%E) 10.5 12.0 16.3 12–15 15.8
CHO (%E) 44.3 40.1 50 33.6
Total Fat (%E) 36.1 40.2 41.3 35–38 44.3
SFA (%E) 7.7 7.5 9.3 8–10 13.6
MUFA (%E) 25.8 22.9 21.5 18–20 22.8
PUFA (%E) 2.5 5.6 6.9 8–10 7.9
Alcohol (%E) 4 4 - ≤5% 1.5
Fibre (g/d) - 46.7 - >25 g 36.4
Linoleic acid n-6 (g) - 15.6 14.1 - 15.1
α-linolenic acid n-3 (g) - 1.5 1.6 - 1.6
EPA (g) - 0.44 - - -
DHA (g) - 0.48 - - -
Total LCN3s (mg) - - - - 200.3
Key outcome All-cause mortality CHD HbA1c ↓CVD complications ↓CVD risk liver fat insulin resistance
Abbreviations: PREDIMED: Prevención con Dieta Mediterráne, Medi-RIVAGE: Mediterranean Diet, Cardiovascular Risks and Gene Polymorphisms, CHO: carbohydrates; SFA: saturated
fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; LCN3s: long chain omega 3 fatty acids;
CHD: coronary heart disease; CVD: cardiovascular disease; NAFLD: non-alcoholic fatty liver disease. -: indicates that values were not published and/or measured; * The PREDIMED trial
included two Mediterranean Diet (MD) arms; one with the provision of extra virgin olive oil (EVOO) and the other with nuts. Results presented are a mean of the consumption data
presented from the two groups; ˆ Recommended diet refers to the diet prescribed; therefore, a participant would receive the described macro- and micronutrient composition if they were
100% adherent.
Nutrients 2018, 10, 465 5 of 20
Table 1 captures the nutrient composition from trials where substantial benefits were demonstrated
with the prescription of the MD. Benefits were defined as improvements in outcome measures in
a range of chronic diseases or where feasibility in an Australian population was shown.
Of note, the landmark LYON diet heart study was clearly the most impressive secondary
prevention trial using a Mediterranean style diet to prevent secondary myocardial infarcts; however,
the dietary intervention model of this trial was not used to inform our intervention model due to major
differences in fat type. The LYON heart study had a heavy reliance on high alpha-linolenic acid (ALA)
canola oil and margarine which are not documented traditional fats used in the MD [22]. Clinical
trials encompassing traditional MD principles that have been carried out in non-Mediterranean
regions, namely Australia, were feeding trials that provided all meals to participants for the
study duration [4,19]. These trials demonstrated ‘proof of concept’ that positive health outcomes
can be achieved for chronic disease states in Australian populations with consumption of a MD.
Ongoing provision of complete meals is not achievable and is cost prohibitive in clinical trials and does
not adequately represent the feasibility of implementing this dietary pattern in a free living population.
Therefore, the Australian dietary intervention developed and described herein encompasses the
traditional MD patterns for application in free living participants [13].
2.2. Step Two: Identification of the Key Food-Based Components of a MD with Strong Published Evidence of
Health Benefits
Using the nutrient profile derived in step one, food components with health promoting effects
were used to formulate a meal plan. When translating optimal levels of essential nutrients into
food-based recommendations, references in Table 1 were used as a guide, as were the Hellenic dietary
guidelines [23]. It is worth noting that since the development of this MD model intervention model,
the Hellenic dietary guidelines have been updated. Cross referencing with published MD food
group recommendations, labelled ‘commandments’, was also carried out [24]. Determination of key
food-based recommendations and a review of the evidence-based mechanisms surrounding these
dietary components were conducted; these are summarised in Table 2.
Table 2. Nutrient composition of the Australian Mediterranean Diet *.
Nutrients Australian Mediterranean Diet Composition
Energy (MJ) 9.4
Protein (%E) 15.8
CHO (%E) 33.8
Added sugar (%E) 5.2
Total fat (%E) 41.8
SFA (%E) 8.9
MUFA (%E) 22.3
PUFA (%E) 10.6
Alcohol (%E) 2.4
Fibre (g/d) 41.1
Linoleic acid n-6 (g) 18.7
α linolenic acid n-3 (g) 4.9
Total LCN3s (mg) 932
* This nutrient profile was calculated by entering two-week food diaries into the software program Foodworks
7™ (Xyris software Australia Pty Ltd.). Abbreviations: CHO: carbohydrates; SFA: saturated fatty acids; MUFA:
monounsaturated fatty acids; PUFA: polyunsaturated fatty acids, LCN3s: long chain omega 3 fatty acids.
For both steps one and two, there was also consideration of other evidence-based, disease specific
dietary recommendations. For example, for CVD patients, the National Heart Foundation guidelines
were incorporated, and for NAFLD patients, alcohol recommendations were kept to the lower end
of the suggested range. This was important to ensure that the MD model dietary model did not was
consistent with established clinical guidelines for these medical conditions.
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2.3. Step Three: Development of a Two-Week Meal Plan Based on the Nutrient Composition Profile and the Key
Food Intake Recommendations Identified in the Previous Steps
Based on steps one and two, a two-week meal plan, suitable for an Australian multiethnic
population was developed (Figure S1). The meal plan was based on the macro and micronutrients
and food-based components consistent with a traditional MD. These meal plans were analyzed using
a standard food analysis program, Foodworks 7™, to ensure nutrient composition was consistent
with the desired profile as identified in step one. The two-week meal plan also incorporated other
key elements of the MD highlighted in step two, including combinations and preparation of foods
described as part of the MD cuisine.
2.4. Step Four: Identification of Potential Barriers and Proposal of Strategies for Translating MD into the
Australian Population
The studies presented are summarized in Tables 1 and 2 and were used to determine the perceived
feasibility of the intervention through highlighting potential barriers for the translation of a MD into
the Australian population. To overcome these barriers, a theoretical framework encompassing a SWOT
(strengths, weaknesses, opportunities, threats) analysis was conducted. This was carried out to identify
barriers that were likely to occur and embed strategies within the MD model to overcome these.
This SWOT analysis was conducted alongside the experience and expertise of practising dietitians
and researchers to ensure appropriate strategies were embedded into the intervention with the aim of
addressing the perceived barriers identified.
3. Practical Strategies Related to Each Specific Aim
3.1. Nutrient Composition Profiles of Other MD Interventions Delivered to Mediterranean and Australian
Populations
The rationale for the MD intervention model, including the composition, specific ingredients
and cooking methods, is discussed throughout this section. As described in step one of the previous
section, a prospective cohort trial as well as four other clinical trials [4,19–21] were used to document
the ideal nutrient components of the MD, and their reported nutrient data is summarised in Table 1.
The single observational study and the four clinical trials identified in step one were used to derive
desirable macro and micronutrient ranges to inform the dietary prescription of the MD model.
The application of this Mediterranean diet model will determine whether this diet can be
translated to the Australian, multiethnic population and whether a MD pattern is sustainable in
the long term. Furthermore, the MD model intervention is being tested within two clinical trials
that are currently underway [13] to determine the efficacy, feasibility and sustainability of delivering
this intervention in Australian cohorts with chronic diseases, such as Coronary Heart Disease (CHD)
and NAFLD.
3.2. Macronutrient Profile of the MD Model
As well as the nutrient compositions described in Table 1, this section provides an overview of
the macronutrient composition and corresponding foods for the MD model intervention. The MD
model intervention is a ‘high fat’ diet, with fat comprising, at the macronutrient level, between 35%
and 45% of energy intake. At least 50% of the energy from fat is from monounsaturated fatty acids
(MUFAs) and the remaining energy contribution comes from polyunsaturated fatty acids (PUFAs) and
saturated fatty acids (SFAs). Protein contributes 15–20% of total energy, and carbohydrates contribute
35–40%. This MD intervention also includes moderate amounts of alcohol which may contribute up to
5% of total energy, which is within the recommendations set by the Australian National Health and
Medical Research Council (NHMRC) [25]. The importance of the specific nutrient profiles within the
MD model and how they impact on chronic disease risk factors are described below.
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3.2.1. Fats
Monounsaturated Fatty Acids
This MD model intervention emulates the traditional MD in that it is high in MUFAs, mainly due
to the daily consumption of Extra Virgin Olive Oil (EVOO), the predominant culinary fat used in the
diet. While there are other oils that are classed as high MUFA, they do not contain the same level of
MUFA as EVOO. Importantly, EVOO contains an abundance of polyphenols which are thought to
drive the anti-inflammatory and antioxidant benefits attributed to the MD diet [26,27].
Polyunsaturated Fatty Acids
PUFAs are also a key nutrient encompassed in the MD intervention. These are sourced from
a variety of foods, including nuts, seeds, olive oil and fish. Long chain omega-3 fatty acids, namely
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are particularly abundant in marine
dietary sources. The plant-derived essential PUFA, alpha linoleic acid, is derived from staple dietary
components, such as wild edible greens and nuts and seeds. These omega-3 rich PUFAs are critical for
achieving a more favourable omega-6 (n-6) to omega-3 (n-3) ratio within the diet. A traditional Cretan
(Greek) MD is characterised by a 2:1 ratio, while Western diets are closer to 20:1 [28]. An elevated n-6:n-3
ratio mediates detrimental vascular changes and limits anti-inflammatory processes, which likely
exacerbates oxidative stress, increasing the risk and severity of chronic diseases [29]. The MD model
diet developed for our dietary interventions and presented in this manuscript achieved a favourable
n-6:n-3 ratio close to 3:1, reflected in Table 2.
Saturated Fatty Acids
SFAs constitute a small proportion of the overall MD model intervention—less than a 10%
contribution to total energy consumption. The small SFA component of the diet is derived from
staple MD components, such as EVOO, nuts and seeds and animal-based products, such as yogurt
and small amounts of meat. SFA-rich products such as processed foods and large amounts, or
frequent consumption of, animal products are not a feature of the traditional MD, nor were these foods
incorporated into our MD model [30].
3.2.2. Carbohydrates
Carbohydrates contribute between 35–40% of energy in the MD model intervention. The focus
is on whole grains which are processed minimally and never refined. Traditionally, these included
sourdough bread, potatoes, rice and pasta. The accessibility of ‘true’ sourdough bread is not readily
available in Australian supermarkets. Thus, soy and linseed bread was recommended as an alternative
which also served to increase dietary alpha-linoleic acid. The traditional MD was consumed ad libitum;
therefore, portions are not a key feature of the MD model intervention. However, given the quantities
of carbohydrate consumed in Australian populations [31], to achieve the desired macronutrient
contribution, examples of appropriate portions for carbohydrate-based foods were provided within
the principles of the MD intervention to moderate intake.
3.2.3. Protein
The MD model is a predominantly plant-based diet, and animal proteins are consumed in small
amounts [28]. Thus, a lot of dietary protein is sourced from a variety of plant-based protein sources,
including legumes, lentils, nuts and seeds. The MD also includes moderate consumption of fish and
animal protein, including dairy, eggs and white meat, and red meat is recommended for less frequent
consumption. The traditional MD included infrequent and small portions of white meat and even less
red meat. However, to ensure acceptability, the MD model intervention allows a maximum quantity of
450 g/week (white and red meat varieties). In the MD model intervention, recommended dairy sources
Nutrients 2018, 10, 465 8 of 20
are predominantly fermented, including yogurt and white cheese, especially feta (Table 2). Of note,
low fat/skim or light dairy alternatives were not traditionally part of a MD; however, modern dairy
production does not follow traditional methods, whereby some full fat options contain additional
fat as cream to enhance ‘creaminess’. Therefore, low fat options were used in the MD intervention
(analysis described in Table 3) to achieve the desired SFA composition as per Table 1 and to ensure
that the Australian National Heart Foundation (NHF) Guidelines were maintained, as appropriate.
This was especially important given that participant cohorts targeted for the application of the MD
model intervention were at risk of, or had CVD [32].
3.2.4. Alcohol
Alcohol, traditionally from red wine, is included and recommended to be consumed with meals
in the MD model. However, individuals not previously consuming alcohol were not encouraged
to commence drinking. The quantity recommended is one to two standard glasses of red wine per
day, which is within the Australian NHMRC alcohol recommendations of <20 g ethanol per day [25].
The maximum contribution of energy from alcohol included in the composition is approximately
5% of total energy. In some instances, alcohol was not recommended. For example, patients who
had progressed NAFLD were advised to avoid alcohol due to the increased risk of hepatocellular
carcinoma [33].
Table 3. The 12 components of a Mediterranean diet and the proposed mechanisms of effect.
Recommendation Practical DietaryApplications Key Components Evidence Based Benefits
Use extra virgin olive oil
(EVOO) as the main
added fat.
Minimum 3–4
tablespoons (60–80 mL)
per day
The highest proportions of
MUFAs and polyphenols squalene
and α-tocopherol are available in
extra virgin olive oil.
Prevention of CHD, cancers and
modification to immune and
inflammatory responses have been
attributed to EVOO.
The high antioxidant content of EVOOs
contributes to health of the vascular
system through improved endothelial
function [34] and has been shown to
inhibit LDL oxidation [35].
EVOO consumption has also been
proposed to improve bone
mineralisation [36].
Eat vegetables with
every meal.
Include 100 g leafy
greens, and 200 g all
other vegetables daily
(cauliflower, zucchini,
eggplant, capsicum etc.).
use onion and
garlic daily;
include 100 g tomatoes
daily; fresh or sofrito
(tomato-based sauce).
Vegetables are the most significant
source of phenolic compounds.
They contain carotenoids, folic
acid, fibre and phytosterols.
Garlic, onion, herbs and spices
also have key benefits. See
Section 3.3.2 for importance of
combining and/or
cooking ingredients.
Flavonoids, are essential bioactive
compounds that provide health benefits
due to their antioxidant effects and have
been associated with improvements in
cognitive function and mood [37].
Traditional diets which are
predominantly plant-based are associated
with lower rates of chronic diseases and
increased longevity [38].
Carotenoids, folic acid and fibre play
important roles in CHD prevention [38].
Phytosterols contribute to reduced serum
cholesterol and CVD risk [39].
Garlic, onions, herbs and spices contain
large amounts of flavonoids or allicin
which have cardiovascular benefits and
also improve cognitive function [40].
Vegetables which are high in potassium,
magnesium and calcium tend to reduce
arterial blood pressure [34,36].
Include at least two
legume meals per week.
Canned or dry legumes
are acceptable; this may
include tofu
(1 serve = 250 g).
This should replace meat
on days when meat is
not consumed.
Legumes are high in fibre, protein,
B vitamins, iron, zinc, calcium,
magnesium, selenium,
phosphorus, copper and
potassium [41]. They provide a
nutritious, nourishing
meat alternative.
Legumes are linked to longevity, and are
a strong predictor of survival [42].
Vegetables have been shown to reduce
serum homocysteine concentrations and
thus coronary events, especially in high
risk individuals [43].
An inverse association between the risk of
T2DM and CHD and legume intake has
been reported [44,45].
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Table 3. Cont.
Recommendation Practical DietaryApplications Key Components Evidence Based Benefits
Eat at least three servings
of fish or shellfish
per week.
Fish (1 serve = 100–150 g);
shellfish (1 serve = 200 g).
Include oily fish at least
1–2 times per week.
Marine long chain omega-3
polyunsaturated fatty acids
provide eicosapentaenoic acid
(EPA) and docosahexaenoic acid
(DHA).
EPA and DHA effectively regulate
haemostatic factors and protect against
cardiac arrhythmias, cancer and
hypertension and help to maintain neural
functions [34,40]. A high intake of fish
and seafood has also been shown to
reduce systolic blood pressure [34,36].
Immunomodulatory effects may improve
inflammatory conditions [46].
Eat red meat less often
and choose smaller
portions. Choose
white meat.
150–200 g weekly of beef,
lamb and, pork.
200–250 g per week of
poultry.
Choose lean varieties,
wild, free range and
grass fed varieties are
encouraged.
Meat is a bioavailable source of
vitamin B12, and iron, selenium,
and zinc and are a good source
of protein.
Excessive amounts of red meat
have been linked to adverse health
outcomes and excess saturated
fatty acids—unfavourable fat
ratios and displacement of more
nutritious alternatives.
Wild, free range and grass fed
varieties are preferred due to the
improved n-6:n-3 ratio [29].
Red meat is a good source of protein
which assists with satiety [47]. Red and
processed meats, especially when
consumed in excess, are associated with
total CVD and cancer mortality [48].
Excessive SFA intake from meat is also
linked to adverse health outcomes [1].
Eat fresh fruit every day. 300g or 2 serves.
Fruit provides fibre, potassium,
vitamins A and C, B vitamins,
folate, flavonoids and terpenes
providing protection against
oxidative processes.
Consumption of fruit has been shown to
reduce the risk of CVD and cancers [49].
Fibre, vitamins, minerals, flavonoids and
terpenes may provide protection against
oxidative processes which drive the onset
and exacerbate chronic diseases [40].
Flavonoids have also been associated
with improvements in cognitive function
and mood [37].
Eat a serve of nuts every
day and dried fruit as a
snack or dessert.
Nuts-1 serve = ~30 g or
1/4 cup or a small
handful daily.
Dried fruit—2
tablespoons or 30 g.
Nuts are a good source of
monounsaturated fats, fibre,
vitamin C and E, selenium,
magnesium, providing an
abundance of antioxidants
including flavonoids, resveratrol,
polyphenols and tocopherols [50].
Monounsaturated fats, phenols,
phytosterols, phytic acid and fibre are
abundant in nuts and are associated with
a reduction in plasma lipids and reduced
incidence of CVD [40]. Nut consumption
has been associated with the prevention
and reversal of oxidative stress [50,51].
Eat dairy every day.
2 serves per day
including milk-1 serve =
250 mL or 1 cup.
Yoghurt preferably
Greek style yoghurt 1
serve = 150 g or 34 cup.
Dairy is a good source of calcium,
vitamin D, phosphorus,
magnesium, zinc, potassium,
vitamins A and B12, and lactic
acid bacteria confer probiotic
effects [52].
Choose mostly fermented dairy
which are higher in potent
beneficial bioactive compounds
from milk such as lactic acid
bacteria [53].
Bioactive milk components have been
shown to be protective in several diseases,
including hypertension, coronary
vascular diseases, obesity, osteoporosis
and cancer [53].
Lactic acid bacteria confer probiotic
effects, including improvements in
gastrointestinal health and immune
response. Yogurt, specifically, may induce
desirable changes in faecal bacterial flora,
potentially reducing the risk of colon
cancer. Yoghurt is also likely to regulate
mouth-to-caecum transit time [54].
Eat cheese in moderation,
about 3 times per week
and preferably feta.
1 serve = 30 g or the size
of a matchbox.
Include wholegrain
breads and cereals with
meals, such as
wholegrain bread, rice,
pasta and potato.
1 serve = 1 slice of bread
or; 12 cup or; 50–60 g
cooked pasta/rice or; 1
small 100 g potato.
Wholegrains are a good source of
fermentable carbohydrates
including fibre, resistant starch,
and oligosaccharides. They
contain phytochemicals,
antioxidants including trace
minerals, phenolic compounds,
lignans and B group vitamins
including folate, vitamin E,
minerals iron, magnesium, copper
and selenium [55].
Components such as fibre, antioxidants
and vitamins and minerals promote
health and may be protective against
cancer, CVD, T2DM and obesity [56,57].
Production of short chain fatty acids
through indigestible carbohydrates
promote reduced serum cholesterol levels
and decrease cancer risk [58].
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Table 3. Cont.
Recommendation Practical DietaryApplications Key Components Evidence Based Benefits
Have sweets or sweet
drinks in moderate
amounts and on special
occasions only.
Preferably home made.
Homemade varieties have key
ingredients that are encouraged in
the MD, such as nuts, EVOO and
milk and are less refined and
lower in SFA.
Liver fat accumulation may be attributed,
at least in part, to excess dietary sugar
consumption, especially from fructose,
which increases the levels of enzymes
involved in hepatic de-novo lipogenesis
[59,60].
Consume up to 3 eggs
per week.
Free range or omega-3
varieties.
Eggs are a good source of protein,
choline, selenium, vitamin B12,
riboflavin, phosphorus and fat
soluble vitamins A, D and E. They
are a bioavailable source of
carotenoids; lutein and
zeaxanthin, [61]. Free range and
omega-3 enriched varieties have
higher amounts of omega-3 fatty
acids [62].
The benefits of eggs, including the
provision of protein and micronutrients
including vitamins, minerals and
carotenoids may prevent age related
macular degeneration and some
cancers [61].
A limit to egg consumption is set to
achieve the desired fat ratios in line with
other MD guidelines [23].
OPTIONAL
Consume wine in
moderation.
Choose red wine. Have
0–2 glasses per day, (100
mL per glass) and
always with meals. Do
not get drunk.
Red wine contains phenolic
compounds with high antioxidant
properties. For example, red wine
has higher amounts of the stilbene
polyphenol, resveratrol, compared
with white wine [63].
Red wine provides polyphenols whose
antioxidant activity may contribute to the
cytoprotective effects. Resveratrol has
been found to protect the heart and
kidneys from ischaemia-reperfusion
injury and has a likely positive effect on
endothelial function (vasodilation) with
prolonged moderate consumption [64,65].
3.3. Identification of the Key Food-Based Components of a MD with Strong Published Evidence of Health Benefits
The food-based recommendations developed in step two are presented in Table 2. Scientific
literature was used to support the development of these recommendations, and identification of
components which include key mechanisms that drive optimal health outcomes for the management
of chronic diseases are also highlighted in Table 2.
3.3.1. Food Groups
The food group recommendations in Table 2 are based upon documented MD ‘commandments’ [24].
Table 2 highlights these adapted food-based recommendations which were designed to be easy for
participants to understand and interpret. Education material outlining these dietary recommendations
and how they could be applied has been designed to be provided to participants in the initial dietary
consultation, with accompanying pictures to aid translatability (Figures S2 and S3). Table 2 also highlights
the proposed mechanisms and evidence-based benefits of each recommendation—these were not included
in patient resources.
3.3.2. Cuisine
The term cuisine refers to the method of cooking which is often characteristic to a country or
region [10]. Cooking includes the fusion of different ingredients, which has been shown to have
additional nutritional benefits compared with its isolated and/or uncooked counterparts. Specifically,
the addition of olive oil to tomatoes during cooking considerably increases the absorption of lycopene
(a carotenoid linked to reduced rates of certain cancers and heart disease) [10]. Furthermore,
the antioxidant capacity of salads has been assessed with and without the addition of aromatic
herbs. Lemon balm and marjoram (1.5% (w/w)) increased antioxidant capacity by 150% and 200%,
respectively [66]. In terms of salad dressings, the combination of EVOO and wine or apple vinegar
gave the greatest increase in antioxidant capacity [66].
Given the benefits of cuisine in the MD pattern, it was important that cooking and preparation
methods were captured in this MD model diet intervention. When providing dietary recommendations
concerning cuisine for participants in this intervention there were two key areas embedded into the
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dietary intervention design, and these were emphasised during consultations: (1) herbs and spices and
(2) cooking. These are elaborated upon below.
3.3.3. Herbs and Spices
Culinary herbs and spices are a part of the traditional MD, where they are used to flavour most
dishes, and many are thought to have medicinal properties based on their ability to heal [28]. It is
thought that the enhancement and depth of flavour resulting from the addition of herbs and spices
contributes, at least in part, to the enjoyment and palatability of MD meals and may therefore encourage
sustainability. The evidence in modern science for the benefits of the phytonutrients found in culinary
herbs and spices continues to grow. Polyphenols have been associated with improved health outcomes
due to the antioxidant capacity of these phytonutrients and thus, an increased quantity and improved
bioavailability of polyphenols through dietary cuisine is desirable [27]. It is well established that
herbs and spices are a concentrated source of polyphenols; for example, the polyphenol contents in
100 g of both oregano and carrot are 935 vs. 58 mg gallic acid equivalents (GAE), respectively [67,68].
It is also well accepted through other dietary guidelines, such as those endorsed by the Australian
NHF, that flavour enhancement using herbs and spices can reduce the addition of excessive salt
(sodium) to meals, which is associated with hypertension [32]. The element of cuisine was a key
consideration within the development of the MD intervention to ensure replication of these health
benefits. To encourage the addition of herbs and spices in meal preparation, recipes and meal plans
were provided to illustrate how to cook with these ingredients.
3.3.4. Cooking
In order to achieve the benefits of combining ingredients and replicating the benefits of a ‘cuisine’
from the MD dietary pattern, traditional cooking practices are encouraged. In addition, cooking skills
and cooking itself are linked to improved health outcomes [69,70]. Encouraging participants to cook
facilitates dietary changes becoming part of lifestyle and behaviour, assisting in sustaining the changes,
and thus achieving benefits.
Of note, many participants who are involved in clinical trials are either not willing to, or unable
to prepare foods and cook meals for a range of reasons. The need for fast and convenient foods
is well recognised in today’s busy lifestyles. To accommodate for such lifestyles, resources were
provided to assist participants to ‘assemble’ meals with choices that required minimal preparation.
These convenient options enabled nutritious choices, while retaining key elements of the MD model
without the need for expansive cooking skills or equipment. These quick and easy meal options were
designed within a resource that could be provided to all participants but was emphasised to those who
had limited cooking skills or for meals such as lunch at work where there was limited time and/or
access to cooking equipment. Figure 2 highlights how these types of nutritious, MD-inspired cook-free
meals were modelled in the resource developed for provision to participants (Figure S4)). This resource
was supplied to participants as part of a toolkit to enable them to implement the principles of this diet
within their own diet and lifestyle.
3.3.5. Eating Together
A key aspect of the traditional MD pattern is the emphasis of eating together. Food pyramids
which depict MD often include a component showing people sharing meals [30]. This element is
featured because it is the essence of the MD culture. It is thought that the table acts as a unifier and
gives a sense of community [30,71,72]. This ideology was captured within our dietary intervention by
recommending social interaction such as family meals or eating with others.
3.3.6. Being Mindful
A key part of the traditional MD is the notion of eating to appetite. Thus, to assist in facilitating
the inclusion of this ad libitum approach, elements of mindfulness are included as a part of the
Nutrients 2018, 10, 465 12 of 20
MD intervention delivery. As well as eating with others, participants are encouraged to practice
mindfulness between and during meals, avoid electronic devices and screen time during meals, and be
more aware of what they are eating through slower eating, chewing thoroughly and understanding
their hunger and fullness cues [73].
Figure 2. A summary of the MD inspired ‘Cook free’ meals based on the resource provided to study
participants. EVOO: extra virgin olive oil.
3.3.7. Biodiversity and Seasonality, Local and Eco Friendly
Including a predominantly plant-based varied diet is a key component of the MD pattern.
In addition, the MD traditionally focused on local, accessible and seasonal produce. This is important,
as accessible produce is (1) environmentally and eco-friendly due to reduced emissions in production,
storage and transportation; (2) often provides a more nutrient-dense food source; and (3) is usually
more abundant and therefore affordable [30,74]. With regard to the practical application of this
aspect of the dietary intervention, food variety and choices are adapted for the Australian context.
The example provided in Figure 2 extrapolates the key points addressed during a dietary consultation
to achieve practical application of biodiversity and seasonality in the Australian context.
The example shown in Figure 3 for traditional MD and modifications for the Australian context is
by no means exhaustive. It simply showcases one example of flexible implementation of the dietary
intervention. This flexibility allows for seasonal and accessible produce in the Australian context and
accommodates different cultural preferences including what is familiar and acceptable to individuals.
This substitution example is important to ensure that the diet model is feasible and translatable into
multiethnic populations.
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Figure 3. An example which models the practical dietary application of a recommendation from the
traditional Cretan MD in an Australian context. Biodiversity and seasonality are considered.
3.4. A Two-Week Meal Plan Based on the Nutrient Composition Profile and the Key Food Intake
Recommendations Identified in the Previous Steps
The nutrient ranges described in Table 1 in conjunction with the key principles of a MD described
in Table 2 guided the development of the MD model intervention and the two week meal plans
discussed in this section. The two-week meal plan was analysed in Foodworks™ version 7 and the
macro- and micronutrients that were derived from these menus are reported in Table 3. These meal
plans are available in Figure S1. There were three main meals and three snacks provided per
day. A recipe book [24] detailing the preparation of all the meals and a shopping list (Figure S5)
accompanied the meal plans. So, while the meal plan was designed to model optimal consumption of
MD, composition was assumed to deviate from this based on individuals’ preferences, satiety, cooking
skills, culture, etc. The recommended meal pattern is an important component of the dietary model
and is described here explicitly to clarify the purpose of each recommendation.
3.4.1. Breakfast
For the first meal of the day, the diet plan aimed to incorporate wholegrains and high contents
of MUFAs and antioxidants while considering what was easily accessible. The options ranged
from porridge with fruit as well as including more traditional components, such as honey and
cinnamon. Soy and linseed bread with either chopped tomatoes, onion, herbs, EVOO and lemon juice
or eggs with stewed tomatoes or avocado were also included. Greek style yogurt with fruit, honey,
cinnamon and nuts were also incorporated into the meal plan. Herbal tea or coffee were included daily.
Less traditional components, such as using low fat dairy, soy and linseed bread, were substituted to
ensure an optimal fat ratio for the meal plan was reached.
3.4.2. Lunch/Dinner
Lunch meals were intended to be high in vegetables, wholegrains and MUFAs. Options ranged from
soy and linseed bread, fish and salad or roast vegetables and feta cheese with EVOO, lentil/legume-based
soups, or leftover dinner meals. Smaller meals were also accompanied by a piece of fruit. Canned fish, for
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example, is a less traditional component of the meals which was included to meet desirable fatty acid
profiles while maintaining the convenience often desired in Western societies.
Dinner meals were also high in vegetables, wholegrains and MUFAs. Most of the meals at dinner
required some cooking, but, as previously mentioned, convenient meal resources could be used in place
of this. Furthermore there were tips on how main meals could be altered or made more convenient.
The main meals at dinner included fish, small portions of white meat twice per week, and red meat,
which was limited to once per week. There were at least two vegetarian days per week and at least
two lentil dishes per week. Meal plans were designed so that meals could be moved around between
meal times, days and weeks to suit individual preferences and time commitments.
3.4.3. Snacks
Snacks primarily composed of Greek yogurt, fresh or dried fruit and/or raw unsalted nuts
providing a source of antioxidants as well as wholegrains, MUFAs and/or protein. There was
an allowance for a small, homemade sweets after dinner twice per week. Snacks provided
an opportunity to include important elements of the MD, such as fermented dairy and healthy
fats from nuts, and were not just ‘fillers’.
3.5. Potential Barriers and Proposed Strategies for Translating MD into the Australian Population
When designing the MD intervention for Australians, a key consideration was whether the
diet would be feasible in a non-Mediterranean population. It is generally easy to replicate desirable
macronutrient contributions such as those described for the MD as macronutrients are broad and
non-specific. However, the task becomes more multifaceted when foods and their combination
through cuisine is considered, to replicate the synergistic effects of the food matrix. When drawing on
more customary recipes from various cuisines, each meal has its own unique flavour profile based
on the region from which it originates. It is therefore important to model how the key elements
of cuisine within the MD could be replicated across a variety of culturally-specific dishes. Table 4
provides an example of a traditional Cretan (Greek) Mediterranean dish called Fasolatha, and models
popular multicultural alternatives which include similar key ingredients and combinations in cooking.
This example demonstrates that macronutrients and foods, even when combined as part of cuisine
from the MD, can be captured and translated across other traditional recipes. This demonstrates that
the MD principles shown to improve health, can be replicated for a multicultural setting, which is both
important and relevant due to the multiethnic landscape of Australia. This also ensures flexibility can
be achieved through individualised dietary advice that can accommodate individual eating preferences.
This substitution therefore enables the MD to be translatable across multiple ethnic groups.
Table 4. Replicating the cuisine in a traditional Cretan Mediterranean dish across different cultures
and cuisines.
Cuisine Greek (Cretan) Middle Eastern Indian Chinese Western
Meal Fasolatha Mujadara Dhal Mapo Tofu HomemadeBaked beans
Key ingredients
Legumes,
onions, garlic,
tomato, herbs,
EVOO
Lentils, rice, onions,
spices, EVOO
Lentils onion,
garlic,
tomatoes, ghee
Tofu, garlic scallions,
peppers, ginger, soy
sauce +/− pork, peanut
+/− sesame oils
Legumes,
onion, garlic,
tomato,
vegetable oil
Fat Modifications - - Replace part or all added fat with EVOO
Abbreviations: EVOO: extra virgin olive oil, -: indicates no change was made or required.
4. General Overview and Future Implications
This paper described the nutrient and food-based components of a traditional Mediterranean diet
using data from seminal trials and a cohort trial including dietary intakes of people from Crete in the
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1950s, considered the archetypal traditional Mediterranean diet. This information was used to model
the development of a MD model for specific use in two multiethnic cohorts with chronic diseases:
CVD [14] and NAFLD [13].
The MD model intervention includes specific dietary prescription, including a breakdown of
macro and micronutrients and food components. This allows for transparency when reviewing
literature and thus optimal analysis of dietary adherence and translation into other research trials and
clinical practice. This belief around ensuring transparency was inherent in the modelling of this paper
through the development and design of the MD model intervention and showed that the components
of the Mediterranean cuisine [20,30] could be maintained across a number of different cultural cuisines.
There is a strong rationale for assessing the efficacy of the MD in a Western, multicultural population
where there is a need to identify a superior dietary pattern that can prevent and manage the growing
epidemic of chronic diseases. This dietary pattern should also be assessed for its ability to be achieved
and sustained by individuals. Furthermore, the MD model described herein has been developed for
application within free living populations. This is an important strength of this dietary intervention
model because theoretically, if adopted by individuals, it is more likely to be sustained. Sustainability
is an outcome that is critical for the management of chronic diseases.
Having comprehensively reviewed the key nutrients, foods and mechanisms which facilitate
health benefits, the development of this MD model intervention is anticipated to be comparable to
interventions delivered in the Mediterranean basin. The MD model intervention is consistent with
the traditional MD, being a predominantly plant-based diet high in dietary fat, predominantly from
MUFA from EVOO consumption. The MD model intervention reported in this paper also features
moderate amounts of fermented dairy, fish and white meat with minimal amounts of red meat.
White and red meat portions are higher than those consumed as part of a traditional MD, where
an allowance of 450 g/week was developed in accordance with successful clinical trials described
in Tables 1 and 2. This resulted in a slightly higher total protein recommendation in the MD model
(Table 3) compared with percentages reported in the traditional MD counterpart. Furthermore, there is
an increased amount of prescribed α-linoleic acid and total long chain n-3s included within the MD
model intervention model in an effort to improve the n6:n3 ratio consumed, which is indicated in
clinical practice guidelines for CVD.
This intervention is in line with the whole diet approach for MD, which has been shown to be more
healthful compared to isolated nutrients [9]. As well as a whole of diet approach, the inclusion of cuisine
means that the MD model intervention incorporates a combination of foods and optimises health
outcomes based on the enhanced benefits of the food matrix and the preparation of these combinations.
Incorporating elements of cuisine such as combining EVOO with herbs and tomatoes resulted
in the improved bioavailability of antioxidants and micronutrients; however, preparation may be
considered challenging or not suitable for individuals who seek or require convenient options.
To overcome this potential barrier the MD model intervention includes a range of non-cooking meal
options for participants to ensure convenience, optimise consistency amongst dietary adherence and
to enable sustainability. To date we are not aware of any direct comparison surrounding the effects
of cuisine in cooked and raw meals. It is also likely that given the complexity around food and its
constituents, results would be variable across specific foods and antioxidants.
One of the other key predicted barriers with application of a MD in non-Mediterranean countries,
such as Australia, is the adaptability to other cultural preferences. This has been highlighted as
a perceived barrier in other countries who have considered the application of a MD for the prevention
and management of chronic diseases [75]. This paper showcased some practical solutions surrounding
how to apply MD principles within other cultural dishes. In particular, the demonstration of
the commonalities between ingredients and combinations from traditional dishes from range of
countries was presented and how the composition and cuisine could be optimised with only minor
recipe changes.
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5. Conclusions
The MD model intervention maintained traditional dietary components to ensure that reported
health benefits could be preserved while the context was adapted and evolved to suit an Australian
multiethnic population. There were multiple factors that were considered, and thus, steps were
developed to include strong evidence base and strategies surrounding potential barriers were applied
to achieve this. Firstly, an optimal evidence-based dietary prescription which encompassed nutrition
composition, ingredients and food combinations which were likely to elicit health benefits was adopted.
Next, the dietary prescriptions were designed in a way that could be implemented across multiple
cultures. This MD model is currently being assessed for acceptability and feasibility for participants
with chronic diseases in two clinical trials. This MD model intervention demonstrates that it is possible
to translate the key elements of the traditional MD to populations outside the Mediterranean region
to increase the likelihood of acceptability and sustainability. Furthermore, this paper indicates the
need for a consistent definition to describe the MD to ensure the key elements are captured and
translated so that the translated MD model retains authenticity. The MD model and accompanying
resources described herein can be used by nutrition researchers for future clinical trials adopting a MD.
In addition, they may be used by health practitioners in the care of their patients with chronic diseases
and by policy makers to provide evidence-based food guidelines for the prevention and management
of many chronic diseases.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/4/465/s1,
Figure S1: Mediterranean Diet: two week cycle menu, Figure S2: Mediterranean Dietary Guidelines- Summary,
Figure S3: Mediterranean Diet Pyramid, Figure S4: “No Cooking” Meal Options, Figure S5: Shopping List.
Acknowledgments: This work was supported by an Australian Government Research Training Program
Scholarship (ESG).
Author Contributions: E.S.G. and T.K. designed the dietary intervention and resources with the support of A.C.T.
and C.I., E.S.G. and H.L.M. delivered the dietary intervention and application of the intervention design. E.S.G.
drafted the manuscript. All authors contributed to the critical review and approval of the final manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Sofi, F.; Macchi, C.; Abbate, R.; Gensini, G.F.; Casini, A. Mediterranean diet and health status: An updated
meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014, 17, 2769–2782.
[CrossRef] [PubMed]
2. Sofi, F.; Abbate, R.; Gensini, G.F.; Casini, A. Accruing evidence on benefits of adherence to the mediterranean
diet on health: An updated systematic review and meta-analysis. Am. J. Clin. Nutr. 2010, 92, 1189–1196.
[CrossRef] [PubMed]
3. Itsiopoulos, C.; Hodge, A.; Kaimakamis, M. Can the mediterranean diet prevent prostate cancer? Mol. Nutr.
Food Res. 2009, 53, 227–239. [CrossRef] [PubMed]
4. Ryan, M.C.; Itsiopoulos, C.; Thodis, T.; Ward, G.; Trost, N.; Hofferberth, S.; O’Dea, K.; Desmond, P.V.;
Johnson, N.A.; Wilson, A.M. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in
individuals with non-alcoholic fatty liver disease. J. Hepatol. 2013, 59, 138–143. [CrossRef] [PubMed]
5. Dhalla, N.S.; Temsah, R.M.; Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. Hypertens.
2000, 18, 655–673. [CrossRef] [PubMed]
6. Khansari, N.; Shakiba, Y.; Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause
of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3, 73–80. [CrossRef]
[PubMed]
7. Esposito, K.; Marfella, R.; Ciotola, M.; Di Palo, C.; Giugliano, F.; Giugliano, G.; D’Armiento, M.; D’Andrea, F.;
Giugliano, D. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular
inflammation in the metabolic syndrome: A randomized trial. JAMA 2004, 292, 1440–1446. [CrossRef]
[PubMed]
Nutrients 2018, 10, 465 17 of 20
8. Estruch, R. Anti-inflammatory effects of the Mediterranean diet: The experience of the PREDIMED study.
Proc. Nutr. Soc. 2010, 69, 333–340. [CrossRef] [PubMed]
9. Widmer, R.J.; Flammer, A.J.; Lerman, L.O.; Lerman, A. The mediterranean diet, its components,
and cardiovascular disease. Am. J. Med. 2015, 128, 229–238. [CrossRef] [PubMed]
10. Fielding, J.M.; Rowley, K.G.; Cooper, P.; O’Dea, K. Increases in plasma lycopene concentration after
consumption of tomatoes cooked with olive oil. Asia Pac. J. Clin. Nutr. 2005, 14, 131–136. [PubMed]
11. Australian Bureau of Statistics. Census Reveals a Fast Changing, Culturally Diverse Nation; Australian
Government: Canberra, Australia, 2017.
12. Dinu, M.; Pagliai, G.; Casini, A.; Sofi, F. Mediterranean diet and multiple health outcomes: An umbrella
review of meta-analyses of observational studies and randomised trials. Eur. J. Clin. Nutr. 2018, 72, 30–43.
[CrossRef] [PubMed]
13. Papamiltiadous, E.S.; Roberts, S.K.; Nicoll, A.J.; Ryan, M.C.; Itsiopoulos, C.; Salim, A.; Tierney, A.C.
A randomised controlled trial of a Mediterranean dietary intervention for adults with non alcoholic fatty
liver disease (MEDINA): Study protocol. BMC Gastroenterol. 2016, 16, 14. [CrossRef] [PubMed]
14. Itsiopoulos, C.; Kucianski, T.; Mayr, H.L.; van Gaal, W.J.; Martinez-Gonzalez, M.; Vally, H. The AUStralian
MEDiterranean Diet Heart Trial (AUSMED Heart Trial): A randomised clinical trial in secondary prevention
of coronary heart disease in a multi-ethnic Australian population: Study Protocol. Am. Heart J. 2018.
under review.
15. Keys, A.; Mienotti, A.; Karvonen, M.J.; Aravanis, C.; Blackburn, H.; Buzina, R.; Djordjevic, B.; Dontas, A.;
Fidanza, F.; Keys, M.H.; et al. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol.
1986, 124, 903–915. [CrossRef] [PubMed]
16. Keys, A.; Menotti, A.; Aravanis, C.; Blackburn, H.; Djordevicˇ, B.S.; Buzina, R.; Dontas, A.S.; Fidanza, F.;
Karvonen, M.J.; Kimura, N.; et al. The seven countries study: 2,289 deaths in 15 years. Prev. Med. 1984, 13,
141–154. [CrossRef]
17. Trichopoulou, A.; Vasilopoulou, E.; Lagiou, A. Mediterranean diet and coronary heart disease: Are
antioxidants critical? Nutr. Rev. 1999, 57, 253–255. [PubMed]
18. Trichopoulou, A.; Lagiou, P. Healthy traditional mediterranean diet: An expression of culture, history,
and lifestyle. Nutr. Rev. 1997, 55, 383–389. [CrossRef] [PubMed]
19. Itsiopoulos, C.; Brazionis, L.; Kaimakamis, M.; Cameron, M.; Best, J.D.; O’Dea, K.; Rowley, K. Can the
mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study. Nutr.
Metab. Cardiovasc. Dis. 2011, 21, 740–747. [CrossRef] [PubMed]
20. Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.-I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.;
Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl.
J. Med. 2013, 368, 1279–1290. [CrossRef] [PubMed]
21. Vincent-Baudry, S.; Defoort, C.; Gerber, M.; Bernard, M.C.; Verger, P.; Helal, O.; Portugal, H.; Planells, R.;
Grolier, P.; Amiot-Carlin, M.J.; et al. The MEDI-RIVAGE study: Reduction of cardiovascular disease risk
factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am. J. Clin. Nutr. 2005, 82,
964–971. [CrossRef] [PubMed]
22. Leaf, A. Dietary prevention of coronary heart disease: The lyon diet heart study. Circulation 1999, 99, 733–735.
[CrossRef] [PubMed]
23. Ministry of Health and Welfare. Dietary Guidelines for Adults in Greece. Arch. Hell. Med. 1999, 16, 516–524.
24. Itsiopoulos, C. The Mediterranean Diet; Macmillan Publishers: Melbourne, Australia, 2013.
25. National Health and Medical Research Council. Australian Guidelines to Reduce Health Risks from Drinking
Alcohol. Available online: https://www.nhmrc.gov.au/health-topics/alcohol-guidelines (accessed on
25 May 2016).
26. Meschino, J.P. How components of the Mediterranean diet reduce heart disease and stroke risk. Dyn. Chiropr.
2013, 31, 8.
27. Ross, S.M. Effects of extra virgin olive oil phenolic compounds and the Mediterranean diet on cardiovascular
health. Holist. Nurs. Pract. 2013, 27, 303–307. [CrossRef] [PubMed]
28. Simopoulos, A.P.; Sidossis, L. What is so special about the traditional diet of Greece. World Rev. Nutr. Diet.
2000, 87, 24–42. [PubMed]
29. Simopoulos, A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother.
2002, 56, 365–379. [CrossRef]
Nutrients 2018, 10, 465 18 of 20
30. Bach-Faig, A.; Berry, E.M.; Lairon, D.; Reguant, J.; Trichopoulou, A.; Dernini, S.; Medina, F.X.; Battino, M.;
Belahsen, R.; Miranda, G.; et al. Mediterranean diet pyramid today. Science and cultural updates.
Public Health Nutr. 2011, 14, 2274–2284. [CrossRef] [PubMed]
31. McNaughton, S.A.; Ball, K.; Crawford, D.; Mishra, G.D. An index of diet and eating patterns is a valid
measure of diet quality in an Australian population. J. Nutr. 2008, 138, 86–93. [CrossRef] [PubMed]
32. Aroney, C.; Aylward, P.; Kelly, A.; Chew, D.; Clune, E. National Heart Foundation of Australia Cardiac
Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006.
Med. J. Aust. 2006, 184, S1–S32.
33. Wang, C.H.; Wey, K.C.; Mo, L.R.; Chang, K.K.; Lin, R.C.; Kuo, J.J. Current trends and recent advances in
diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac. J Cancer Prev. 2015, 16, 3595–3604.
[CrossRef] [PubMed]
34. Psaltopoulou, T.; Naska, A.; Orfanos, P.; Trichopoulos, D.; Mountokalakis, T.; Trichopoulou, A. Olive oil, the
Mediterranean diet, and arterial blood pressure: The Greek European prospective investigation into cancer
and nutrition (EPIC) study. Am. J. Clin. Nutr. 2004, 80, 1012–1018. [CrossRef] [PubMed]
35. Lamuela-Raventós, R.M.; Gimeno, E.; Fito, M.; Castellote, A.-I.; Covas, M.; de la torre-boronat, M.C.;
López-Sabater, M.C. Interaction of olive oil phenol antioxidant components with low-density lipoprotein.
Biol. Res. 2004, 37, 247–252. [CrossRef] [PubMed]
36. Stark, A.H.; Madar, Z. Olive oil as a functional food: Epidemiology and nutritional approaches. Nutr. Rev.
2002, 60, 170–176. [CrossRef] [PubMed]
37. Kinoshita, T.; Lepp, Z.; Chuman, H. Approach to novel functional foods for stress control 1. Toward
structure-activity relationship and data mining of food compounds by chemoinformatics. J. Med. Investig.
2005, 52, 240–241. [CrossRef]
38. Kushi, L.H.; Lenart, E.B.; Willett, W.C. Health implications of mediterranean diets in light of contemporary
knowledge. 1. Plant foods and dairy products. Am. J. Clin. Nutr. 1995, 61, 1407S–1415S. [CrossRef] [PubMed]
39. Ortega, R.M.; Palencia, A.; López-Sobaler, A.M. Improvement of cholesterol levels and reduction of
cardiovascular risk via the consumption of phytosterols. Br. J. Nutr. 2006, 96, S89–S93. [CrossRef] [PubMed]
40. Serra Majem, L.; García Alvarez, A.; Ngo de la Cruz, J. Dieta Mediterránea: Características y beneficios para
la salud. Arch. Latinoam. Nutr. 2004, 54, 44–51. [PubMed]
41. Kouris-Blazos, A.; Belski, R. Health benefits of legumes and pulses with a focus on Australian sweet lupins.
Asia Pac. J. Clin. Nutr. 2016, 25, 1–17. [PubMed]
42. Darmadi-Blackberry, I.; Wahlqvist, M.L.; Kouris-Blazos, A.; Steen, B.; Lukito, W.; Horie, Y.; Horie, K. Legumes:
The most important dietary predictor of survival in older people of different ethnicities. Asia Pac. J. Clin. Nutr.
2004, 13, 217–220. [PubMed]
43. Samman, S.; Sivarajah, G.; Man, J.C.; Ahmad, Z.I.; Petocz, P.; Caterson, I.D. A mixed fruit and vegetable
concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men.
J. Nutr. 2003, 133, 2188–2193. [CrossRef] [PubMed]
44. Bazzano, L.A.; He, J.; Ogden, L.G.; Loria, C.; Vupputuri, S.; Myers, L.; Whelton, P.K. Legume consumption
and risk of coronary heart disease in US men and women: NHANES I epidemiologic follow-up study.
Arch. Intern. Med. 2001, 161, 2573–2578. [CrossRef] [PubMed]
45. Becerra-Tomás, N.; Díaz-López, A.; Rosique-Esteban, N.; Ros, E.; Buil-Cosiales, P.; Corella, D.; Estruch, R.;
Fitó, M.; Serra-Majem, L.; Arós, F.; et al. Legume consumption is inversely associated with type 2 diabetes
incidence in adults: A prospective assessment from the PREDIMED study. Clin. Nutr. 2017. [CrossRef]
46. Ruxton, C.; Reed, S.C.; Simpson, M.; Millington, K. The health benefits of omega-3 polyunsaturated fatty
acids: A review of the evidence. J. Hum. Nutr. Diet. 2004, 17, 449–459. [CrossRef] [PubMed]
47. Biesalski, H.-K. Meat as a component of a healthy diet—Are there any risks or benefits if meat is avoided in
the diet? Meat Sci. 2005, 70, 509–524. [CrossRef] [PubMed]
48. Sinha, R.; Cross, A.J.; Graubard, B.I.; Leitzmann, M.F.; Schatzkin, A. Meat intake and mortality: A prospective
study of over half a million people. Arch. Intern. Med. 2009, 169, 562–571. [CrossRef] [PubMed]
49. John, J.; Ziebland, S.; Yudkin, P.; Roe, L.; Neil, H. Effects of fruit and vegetable consumption on plasma
antioxidant concentrations and blood pressure: A randomised controlled trial. Lancet 2002, 359, 1969–1974.
[CrossRef]
50. Blomhoff, R.; Carlsen, M.H.; Andersen, L.F.; Jacobs, D.R. Health benefits of nuts: Potential role of antioxidants.
Br. J. Nutr. 2006, 96, S52–S60. [CrossRef] [PubMed]
Nutrients 2018, 10, 465 19 of 20
51. Sabaté, J.; Ang, Y. Nuts and health outcomes: New epidemiologic evidence. Am. J. Clin. Nutr. 2009, 89,
1643S–1648S. [CrossRef] [PubMed]
52. Panesar, P.S. Fermented dairy products: Starter cultures and potential nutritional benefits. Food Nutr. Sci.
2011, 2, 47–51. [CrossRef]
53. Ebringer, L.; Ferencˇík, M.; Krajcˇovicˇ, J. Beneficial health effects of milk and fermented dairy
products—Review. Folia Microbiol. 2008, 53, 378–394. [CrossRef] [PubMed]
54. Bartram, H.-P.; Scheppach, W.; Gerlach, S.; Ruckdeschel, G.; Kelber, E.; Kasper, H. Does yogurt enriched
with bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am. J.
Clin. Nutr. 1994, 59, 428–432. [CrossRef] [PubMed]
55. Slavin, J.L.; Jacobs, D.; Marquart, L.; Wiemer, K. The role of whole grains in disease prevention. J. Am.
Diet. Assoc. 2001, 101, 780–785. [CrossRef]
56. Slavin, J. Whole grains and human health. Nutr. Res. Rev. 2004, 17, 99–110. [CrossRef] [PubMed]
57. Slavin, J.L.; Martini, M.C.; Jacobs, D.R.; Marquart, L. Plausible mechanisms for the protectiveness of whole
grains. Am. J. Clin. Nutr. 1999, 70, 459s–463s. [CrossRef] [PubMed]
58. Cook, S.I.; Sellin, J.H. Review article: Short chain fatty acids in health and disease. Aliment. Pharmacol. Ther.
1998, 12, 499–507. [CrossRef] [PubMed]
59. Goran, M.I.; Walker, R.; Allayee, H. Genetic-related and carbohydrate-related factors affecting liver fat
accumulation. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 392–396. [CrossRef] [PubMed]
60. Jin, R.; Welsh, J.A.; Le, N.-A.; Holzberg, J.; Sharma, P.; Martin, D.R.; Vos, M.B. Dietary fructose reduction
improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients
2014, 6, 3187–3201. [CrossRef] [PubMed]
61. Handelman, G.J.; Nightingale, Z.D.; Lichtenstein, A.H.; Schaefer, E.J.; Blumberg, J.B. Lutein and zeaxanthin
concentrations in plasma after dietary supplementation with egg yolk. Am. J. Clin. Nutr. 1999, 70, 247–251.
[CrossRef] [PubMed]
62. Anderson, K.E. Comparison of fatty acid, cholesterol, and vitamin a and e composition in eggs from hens
housed in conventional cage and range production facilities. Poult. Sci. 2011, 90, 1600–1608. [CrossRef]
[PubMed]
63. Wallerath, T.; Deckert, G.; Ternes, T.; Anderson, H.; Li, H.; Witte, K.; Förstermann, U. Resveratrol,
a ‘polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide
synthase. Circulation 2002, 106, 1652–1658. [CrossRef] [PubMed]
64. Echeverry, C.; Blasina, F.; Arredondo, F.; Ferreira, M.; Abin-Carriquiry, J.A.; Vasquez, L.; Aspillaga, A.A.;
Diez, M.S.; Leighton, F.; Dajas, F. Cytoprotection by neutral fraction of tannat red wine against oxidative
stress-induced cell death. J. Agric. Food chem. 2004, 52, 7395–7399. [CrossRef] [PubMed]
65. Ortega, R. Importance of functional foods in the mediterranean diet. Public Health Nutr. 2006, 9, 1136–1140.
[CrossRef] [PubMed]
66. Ninfali, P.; Mea, G.; Giorgini, S.; Rocchi, M.; Bacchiocca, M. Antioxidant capacity of vegetables, spices and
dressings relevant to nutrition. Br. J. Nutr. 2005, 93, 257–266. [CrossRef] [PubMed]
67. Bower, A.; Marquez, S.; de Mejia, E.G. The health benefits of selected culinary herbs and spices found in the
traditional Mediterranean diet. Crit. Rev. Food Sci. Nutr. 2016, 56, 2728–2746. [CrossRef] [PubMed]
68. Stahl, W. Carrots, tomatoes and cocoa: Research on dietary antioxidants in dusseldorf. Arch. Biochem. Biophys.
2016, 595, 125–131. [CrossRef] [PubMed]
69. Wolfson, J.A.; Bleich, S.N. Is cooking at home associated with better diet quality or weight-loss intention?
Public Health Nutr. 2015, 18, 1397–1406. [CrossRef] [PubMed]
70. Garcia, A.L.; Reardon, R.; McDonald, M.; Vargas-Garcia, E.J. Community interventions to improve cooking
skills and their effects on confidence and eating behaviour. Curr. Nutr. Rep. 2016, 5, 315–322. [CrossRef]
[PubMed]
71. Hoffman, R.; Gerber, M. Evaluating and adapting the mediterranean diet for non-mediterranean populations:
A critical appraisal. Nutr. Rev. 2013, 71, 573–584. [CrossRef] [PubMed]
72. Radd-Vagenas, S.; Kouris-Blazos, A.; Singh, M.F.; Flood, V.M. Evolution of mediterranean diets and cuisine:
Concepts and definitions. Asia Pac. J. Clin. Nutr. 2013, 1–32. [CrossRef]
73. Jordan, C.H.; Wang, W.; Donatoni, L.; Meier, B.P. Mindful eating: Trait and state mindfulness predict healthier
eating behavior. Pers. Indiv. Differ. 2014, 68, 107–111. [CrossRef]
Nutrients 2018, 10, 465 20 of 20
74. Burlingame, B.; Dernini, S. Sustainable diets: The mediterranean diet as an example. Public Health Nutr. 2011,
14, 2285–2287. [CrossRef] [PubMed]
75. Moore, S.; McEvoy, C.; Prior, L.; Lawton, J.; Patterson, C.; Kee, F.; Cupples, M.; Young, I.; Appleton, K.;
McKinley, M.; et al. Barriers to adopting a mediterranean diet in northern European adults at high risk of
developing cardiovascular disease. J. Hum. Nutr. Diet. 2017. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
